Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Washington University’s ‘underdog’ vaccine shows promise

A St. Louis startup has licensed a COVID-19 vaccine developed at Washington University that won’t be one of the first on the market, but could have advantages over other early vaccine contenders. An article in Nature this month described the Washington U. research as one of several “underdog” vaccines that could be important if early candidates fail, or confer only partial protection against COVID-19.